Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial
Listen to this summary
This study aimed to compare the efficacy of niraparib, a PARP inhibitor, versus standard platinum-taxane chemotherapy as neoadjuvant treatment for patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer. The results showed that the overall response rate before interval debulking surgery was significantly lower with niraparib (31.6%) compared to platinum-taxane (70.6%), leading to the early closure of the trial for futility. The safety profiles of both treatments were consistent with previous studies, with no fatal serious adverse events reported.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Gynecologic oncology
View all →Sep 2, 2026 · Gynecologic oncology
Molecular characterization of NSMP endometrial cancer and its relevance for treatment
Aug 29, 2026 · Gynecologic oncology
High rates of venous thromboembolism in endometrial cancer patients requiring systemic therapy: an opportunity for risk assessment and intervention
Aug 28, 2026 · Gynecologic oncology
The science and conduct of surgical trials in gynecologic oncology: A practical framework
Aug 28, 2026 · Gynecologic oncology
Leveraging artificial intelligence in the early detection of ovarian cancer: Development and validation of a risk prediction model
Aug 21, 2026 · Gynecologic oncology
Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups
Aug 20, 2026 · Gynecologic oncology
Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials
More in Obstetrics & Gynecology
View all →Sep 3, 2026 · International urogynecology journal
Robotic-Assisted Early Repair of Vesicovaginal Fistula in a Colon Cancer Patient: A Case Report and Surgical Technique Video
Sep 3, 2026 · Obstetrics and gynecology
The Cardiometabolic Effects of Menopause
Sep 3, 2026 · BMC women's health
Psychometric properties of the Chinese version of the Meno-D in perimenopausal women
Sep 3, 2026 · BJOG : an international journal of obstetrics and gynaecology
Pre-Procedure Predictors of Six-Month Survival After Fetoscopic Laser Ablation for Twin-Twin Transfusion Syndrome (TTTS): Retrospective Observational Study
Sep 2, 2026 · Journal of lower genital tract disease
Heterogeneity in Risk of Recurrent CIN2+ Among Women With Genotype-Specific HPV Detected After Excision: A Cohort Study
Sep 2, 2026 · International urogynecology journal
Obstetric Factors Associated with Pelvic Floor Disorders and Surgery 30 Years After Childbirth: A Prospective Cohort Study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


